Skip to content
More from
Bloomberg
Opinion
relates to Water and Renewables Are Remaking the Middle East
Water and Renewables Are Remaking the Middle East
relates to The U.S. Shouldn’t Limit Its Nuclear Options
The U.S. Shouldn’t Limit Its Nuclear Options
relates to Omicron Is Feeding the Republican Conspiracy Beast
Omicron Is Feeding the Republican Conspiracy Beast
relates to Four Smart Ways to Close Out a Bewildering Tax Year
Four Smart Ways to Close Out a Bewildering Tax Year
relates to Inflation Bonds Are Betting on Team Transitory
Inflation Bonds Are Betting on Team Transitory
relates to Iran Demonstrates It Isn’t Serious About Nuclear Talks
Iran Demonstrates It Isn’t Serious About Nuclear Talks
relates to Climate Tech Investments Can Add Up to Net Zero
Climate Tech Investments Can Add Up to Net Zero
relates to Macron Is Done Being the U.K.’s Border Guard
Macron Is Done Being the U.K.’s Border Guard
relates to Omicron’s Market Risk Is Already Looking Overdone
Omicron’s Market Risk Is Already Looking Overdone
relates to Didi’s Secrets Risk China's Wall Street Future
Didi’s Secrets Risk China's Wall Street Future
Subscriber Only
Technology & Ideas

Vaccines Should Not Be Immune to Market Forces

Letting the wealthy pay for vaccines may help them reach a wider audience eventually.

By
There’s definitely a market for it.

There’s definitely a market for it.

Photographer: Bloomberg

The renowned economist Erik Brynjolfsson recently asked: “At least so far, I haven’t seen any one suggesting to use the market system to allocate vaccines. Not even those who strongly advocate it in other areas. Why is that?”

As one of several people copied at the bottom of the tweet, I feel compelled to take up the challenge.